Buscar resultados de ensayos clínicos

Patrocinado por

Anemia, Refractory - 25 Studies Found

Estado Estudiar
Completed Nombre del estudio: Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias
Condición:
  • Angiodysplasia
  • Vascular Malformations
  • Gastrointestinal Hem
    Fecha: 2015-03-04
    Intervenciones: Drug: Octreotide Two injections of 20 mg will be given monthly.
Terminated Nombre del estudio: A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
Condición: Acute Myeloid Leukemia
Fecha: 2006-08-11
Intervenciones:
  • Procedure: Two post-remission strategies
  • D
Completed Nombre del estudio: Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
Condición:
  • Childhood Myelodysplastic Syndromes
  • de Novo Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Drug: thalidomide Given orally
Completed Nombre del estudio: Tipifarnib in Treating Patients With Myelodysplastic Syndromes
Condición:
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Drug: tipifarnib Given PO
Completed Nombre del estudio: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Condición:
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Other: flow cytometry Correlat
Recruiting Nombre del estudio: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Condición:
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia in Remission
  • Fecha: 2015-09-30
    Intervenciones:
    • Drug: Fludarabine Given IV
Active, not recruiting Nombre del estudio: Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
Condición:
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Myelomonocytic Leukemia
    • Fecha: 2006-11-09
    Intervenciones:
    • Drug: Cyclosporine Given PO
Completed Nombre del estudio: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
Condición:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Myeloid Leukemia in Remission Fecha: 2013-02-07
    Intervenciones:
    • Drug: vorinostat Given PO
Completed Nombre del estudio: Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
Condición:
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndrome
  • Drug: Azacitidine Given intrav
<<< Previous | Next >>>